Belle.ai Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 41

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Belle.ai General Information

Description

Developer of an AI-powered skincare platform designed for precise epidemiology risk assessment. The company's platform identifies more than one thousand skin conditions and variations, including skin cancer, and measures the severity of autoimmune and inflammatory conditions such as acne, psoriasis, eczema, vitiligo, and alopecia areata, enabling healthcare professionals to address the unmet demands for global skin healthcare.

Contact Information

Website
www.belle.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 245 First Street, Riverview II
  • 18th Floor
  • Cambridge, MA 02142
  • United States
+1 (781)
Primary Industry
Decision/Risk Analysis
Corporate Office
  • 245 First Street, Riverview II
  • 18th Floor
  • Cambridge, MA 02142
  • United States
+1 (781)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Belle.ai Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
1. Seed Round 24-Feb-2022 Completed Startup
To view Belle.ai’s complete valuation and funding history, request access »

Belle.ai Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Belle.ai’s complete cap table history, request access »

Belle.ai Patents

Belle.ai Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260311873-A1 Compute system with image diagnostic mechanism and method of operation thereof Pending 07-Apr-2025
US-12437403-B1 Compute system with image diagnostic mechanism and method of operation thereof Active 28-Feb-2025
US-12518385-B1 Compute system with nail ailment diagnostic mechanism and method of operation thereof Active 27-Feb-2025
US-12784213-B2 Compute system with skin pathology mechanism and method of operation thereof Active 31-Jan-2025
US-20260228884-A1 Compute system with skin pathology mechanism and method of operation thereof Active 31-Jan-2025 G06T7/0012
To view Belle.ai’s complete patent history, request access »

Belle.ai Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Belle.ai Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Lifeforce Capital Venture Capital Minority
To view Belle.ai’s complete investors history, request access »

Belle.ai FAQs

  • When was Belle.ai founded?

    Belle.ai was founded in 2021.

  • Where is Belle.ai headquartered?

    Belle.ai is headquartered in Cambridge, MA.

  • What is the size of Belle.ai?

    Belle.ai has 41 total employees.

  • What industry is Belle.ai in?

    Belle.ai’s primary industry is Decision/Risk Analysis.

  • Is Belle.ai a private or public company?

    Belle.ai is a Private company.

  • What is Belle.ai’s current revenue?

    The current revenue for Belle.ai is .

  • How much funding has Belle.ai raised over time?

    Belle.ai has raised $7.5M.

  • Who are Belle.ai’s investors?

    Lifeforce Capital has invested in Belle.ai.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process